All Insights
Showing 49 - 60 of 241
Life Sciences and Healthcare
European Commission publishes proposal for new EU pharmaceutical legislation
The EU Commission is planning to revise the pharmaceutical legislation in Europe to make medicinal products more available, accessible and
Intellectual property
UK sets out the new Science and Technology Framework
Government growth ambitions for critical technologies including AI and future telecoms require regulatory clarity
Tax
Spring Budget 2023 | What tax measures were announced?
A budget for growth but no cuts in tax rates
Life Sciences and Healthcare
Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies
Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in
Regulatory and compliance
Consultation opens on proposed revisions to the Veterinary Medicines Regulations in Great Britain
Businesses involved in the manufacture, distribution and dispensation of veterinary medicinal products should take the opportunity to respond before the
Regulatory Outlook
Products | UK Regulatory Outlook February 2023
Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
Regulatory and compliance
UK NHS suppliers required to commit to net zero by 2050 or lose out on future contract opportunities
From April, bidders for NHS contracts over £5 million must produce a carbon reduction plan
Commercial
Enforcement risks mount in Germany for comparison and intermediary platforms
German watchdog is pursuing misleading behaviour and lack of transparency on ranking, reviews and market coverage
Life Sciences and Healthcare
Telemedicine in Italy takes next step following pandemic regulatory advance
The 'care relationship' between the physician and the patient will be transformed by telemedicine if not superseded
Corporate
2023 predictions: What's on the horizon for US businesses operating in Europe?
By staying ahead of the curve and preparing for changes, US businesses can remain competitive and successful in Europe
Life Sciences and Healthcare
Pharma industry watches as UK Court of Appeal considers issue of plausibility
Decisions to invalidate blood clot drug patents are appealed
Life Sciences and Healthcare
New year brings healthcare professional interaction rule update in Belgium
The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations
